Page last updated: 2024-10-15

3,n(4)-ethanocytosine

Cross-References

ID SourceID
PubMed CID135476780
CHEMBL ID471164
CHEBI ID29147
SCHEMBL ID557383
SCHEMBL ID557382
MeSH IDM0145685

Synonyms (37)

Synonym
3,n(4)-ethanocytosine
55662-66-3
3,n(4)-ethenocytosine
ethenocytosine
CHEBI:29147
imidazo[1,2-c]pyrimidin-5(6h)-one ,
epsilonc
3,n4-ethenocytosine
1h-imidazo[1,2-c]pyrimidin-5-one
CHEMBL471164
imidazo[1,2-c]pyrimidin-5(1h)-one
AKOS006281206
1,5-dihydro-5-oxoimidazo[1,2-c]pyrimidine
imidazo(1,2-c)pyrimidin-5(6h)-one
849035-92-3
AKOS015854510
imidazo[1,2-c]pyrimidin-5-ol
SCHEMBL557383
SCHEMBL557382
6h-imidazo[1,2-c]pyrimidin-5-one
mfcd06800801
3,n4ethenocytosine
SY036604
CS-0238547
FT-0715746
mfcd00056907
CS-0105346
DS-15784
1h,5h-imidazo[1,2-c]pyrimidin-5-one
Q27109963
AMY15894
AC2333
DTXSID30971017
A923154
ZIB03592
EN300-197180
Z1198149460
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
mutagenAn agent that increases the frequency of mutations above the normal background level, usually by interacting directly with DNA and causing it damage, including base substitution.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
organic heterobicyclic compound
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (5)

PathwayProteinsCompounds
DNA Repair25547
Base Excision Repair3523
Base-Excision Repair, AP Site Formation1716
Depyrimidination159
Cleavage of the damaged pyrimidine109

Bioassays (1)

Assay IDTitleYearJournalArticle
AID363285Inhibition of Escherichia coli thymidine phosphorylase at 163 uM2008European journal of medicinal chemistry, Jun, Volume: 43, Issue:6
Xanthine oxidase-activated prodrugs of thymidine phosphorylase inhibitors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (66)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (6.06)18.7374
1990's28 (42.42)18.2507
2000's22 (33.33)29.6817
2010's11 (16.67)24.3611
2020's1 (1.52)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews4 (6.06%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other62 (93.94%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]